Homology Medicines Inc (FIXX) Stock
FIXX is no longer traded. Homology Medicines was delisted from the Nasdaq in March 2024.
Prices on this page are historical; the last trade was March 25, 2024 at $0.93.
Homology Medicines stock price history
FIXX final trading statistics
- Final close
- $0.93
- Final trading day
- Mar 25, 2024
- Market cap at delisting
- $3.02M
- Shares outstanding
- 3.23M
- Final 52-week range
- $0.46 – $1.48
- Avg. volume (final 3 mo.)
- 383,098
- All-time high (split-adj.)
- $546.12 · Apr 2019
- All-time low (split-adj.)
- $0.88 · Mar 2024
- Return since IPO
- -99.7%
- Beta
- -0.11
- Book value / share
- $22.65
- Price / book
- 0.04
Homology Medicines annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $1.16M | -$113.0M | -$1.96 |
| FY2022 | $3.21M | $483.0K | -$1.90 |
| FY2021 | $33.97M | -$95.6M | -$1.69 |
| FY2020 | $2.70M | -$127.1M | -$2.80 |
| FY2019 | $1.67M | -$97.9M | -$2.47 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Homology Medicines Inc
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases in the United States. The company offers proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a nuclease-free gene editing mobility, gene therapy or for various genetic disorders. Its earlier stage product candidates comprising HMI-202, an investigational gene therapy which completed IND-enabling studies for the treatment of metachromatic leukodystrophy; and HMI-104 which completed IND-enabling studies. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.
Homology Medicines stock FAQ
What happened to Homology Medicines stock?
Homology Medicines stock was delisted from the Nasdaq. Its final close was $0.93 on March 25, 2024.
Is FIXX stock still trading?
No. FIXX was delisted from the Nasdaq in March 2024 and no longer trades on a U.S. exchange.
What was the last price of FIXX stock?
FIXX closed at $0.93 on its final trading day, March 25, 2024, for a market value of about $3.02M.
What were Homology Medicines's revenue and earnings in its last full fiscal year?
Homology Medicines reported revenue of $1.16M and net income of -$113.0M in fiscal 2023, its last full year as a public company.
When did Homology Medicines go public?
Homology Medicines Inc stock began trading on March 28, 2018.